Search results for "lh"

showing 10 items of 925 documents

Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats

2010

Abstract Mildronate is a cardioprotective drug, the mechanism of action of which is based on the regulation of l -carnitine concentration. We studied the metabolic effects of treatment with mildronate, metformin and a combination of the two in the Zucker rat model of obesity and impaired glucose tolerance. Zucker rats were p.o. treated daily with mildronate (200 mg/kg), metformin (300 mg/kg), and a combination of both drugs for 4 weeks. Weight gain and plasma metabolites reflecting glucose metabolism were measured. The expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ and target genes was measured in rat heart and liver tissues. Each treatment decreased the blood …

Blood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentPeroxisome proliferator-activated receptorCarbohydrate metabolismImpaired glucose toleranceEatingInternal medicinemedicineAnimalsHypoglycemic AgentsInsulinPPAR alphaLactic AcidObesityRNA MessengerCarnitineCell NucleusPharmacologychemistry.chemical_classificationbusiness.industryMyocardiumInsulinBody WeightLipid Metabolismmedicine.diseaseMetforminRatsRats ZuckerMetforminPPAR gammaDrug CombinationsEndocrinologyGene Expression RegulationMechanism of actionchemistryCarnitine biosynthesismedicine.symptombusinessMethylhydrazinesmedicine.drugEuropean Journal of Pharmacology
researchProduct

Correction of glycaemia and GLUT1 level by mildronate in rat streptozotocin diabetes mellitus model

2011

Anti-ischaemic drug mildronate suppresses fatty acid metabolism and increases glucose utilization in myocardium. It was proposed that it could produce a favourable effect on metabolic parameters and glucose transport in diabetic animals. Rats with streptozotocin diabetes mellitus were treated with mildronate (100 mg/kg daily, per os, 6 weeks). Therapeutic effect of mildronate was monitored by measuring animal weight, concentrations of blood glucose, insulin, blood triglycerides, free fatty acids, blood ketone bodies and cholesterol, glycated haemoglobin per cent (HbA1c%) and glucose tolerance. GLUT1 mRNA and protein expression in kidneys, heart, liver and muscles were studied by means of re…

Blood Glucosemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentClinical BiochemistryBiochemistryStreptozocinDiabetes Mellitus Experimentalchemistry.chemical_compoundInternal medicineDiabetes mellitusDiabetes MellitusmedicineAnimalsBody SizeHypoglycemic AgentsInsulinRNA MessengerRats WistarTriglyceridesGlycated HemoglobinGlucose Transporter Type 1Glucose tolerance testmedicine.diagnostic_testFatty acid metabolismbiologyCholesterolbusiness.industryInsulinFatty AcidsGlucose transporternutritional and metabolic diseasesCell BiologyGeneral MedicineGlucose Tolerance Testmedicine.diseaseRatsEndocrinologychemistrybiology.proteinKetone bodiesGLUT1businessMethylhydrazinesCell Biochemistry and Function
researchProduct

Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats

2011

Mildronate (3-(2,2,2-trimethylhydrazinium) propionate) is an inhibitor of l-carnitine biosynthesis and an anti-ischemic drug. In the present study, we investigated the effects of mildronate in rats following focal cerebral ischemia. Male Wistar rats were subjected to transient occlusion of the middle cerebral artery (MCAO) for 90min, followed by the intraperitoneal administration of mildronate at doses of 100 and 200mg/kg 2h after reperfusion and then daily for an additional 14days. The beam-walking, rota-rod and cylinder tests were used to assess sensorimotor function, and vibrissae-evoked forelimb-placing and limb-placing tests examined responses to tactile and proprioceptive stimulation.…

Brain InfarctionMaleIschemiaStimulationPharmacologyRotarod performance testBrain ischemiaBehavioral NeuroscienceAdjuvants ImmunologicTandem Mass SpectrometryCarnitinemedicine.arterymedicineAnimalsRats WistarStrokeChromatography High Pressure LiquidAnalysis of VarianceDose-Response Relationship Drugbusiness.industryExtremitiesInfarction Middle Cerebral ArteryRecovery of Functionmedicine.diseaseRatsBetaineDose–response relationshipRotarod Performance TestVibrissaeMiddle cerebral arterySystemic administrationbusinessNeuroscienceLocomotionPsychomotor PerformanceMethylhydrazinesBehavioural Brain Research
researchProduct

Emerging dynamics in surfactant-based liquid mixtures: octanoic acid/bis(2-ethylhexyl) amine systems.

2012

This work focuses on the dynamic phenomena emerging in self-assembled transient intermolecular networks formed when two different surfactants are mixed. In particular, the relaxation processes in liquid mixtures composed by bis(2-ethylhexyl)amine (BEEA) and octanoic acid (OA) in the whole composition range has been investigated by dielectric spectroscopy and Brillouin spectroscopy. A thorough analysis of all the experimental data consistently suggests that, mainly driven by acid-base interactions arising when the two surfactants are mixed, supra-molecular aggregates formation causes the slowing down of molecular dynamics. This, in turn, reflects to longer-range relaxations. These changes ha…

Brillouin SpectroscopyChemistryRelaxation (NMR)Intermolecular forceGeneral Physics and AstronomyConductivity..Dielectric spectroscopyMolecular dynamicsLiquid mixturesChemical physicsionic conductivitybis(2-ethylhexyl)amine octanoic acid dielectric spectroscopy Brillouin spectroscopy liquid mixturesOrganic chemistryIonic conductivitySelf-assemblyPhysical and Theoretical Chemistryionic conductivity; Liquid mixtures; Brillouin scatteringBrillouin scatteringSettore CHIM/02 - Chimica FisicaThe Journal of chemical physics
researchProduct

Multi-channel search for squarks and gluinos in root s=7 TeV pp collisions with the ATLAS detector at the LHC

2013

A search for supersymmetric particles in final states with zero, one, and two leptons, with and without jets identified as originating from b-quarks, in 4.7 fb[superscript −1] of √s = 7 TeV pp collisions produced by the Large Hadron Collider and recorded by the ATLAS detector is presented. The search uses a set of variables carrying information on the event kinematics transverse and parallel to the beam line that are sensitive to several topologies expected in supersymmetry. Mutually exclusive final states are defined, allowing a combination of all channels to increase the search sensitivity. No deviation from the Standard Model expectation is observed. Upper limits at 95 % confidence level…

Brookhaven National LaboratoryParticle physicsPhysics and Astronomy (miscellaneous)Supergauge TransformationsContext (language use)ddc:500.253001 natural sciencesStandard ModelSet (abstract data type)CurrentsPions0103 physical sciencesddc:530Sensitivity (control systems)WeakHigh Energy Physics010306 general physicsEngineering (miscellaneous)QCCiencias ExactasPhysicsproton–proton collisionsHadron-Hadron ScatteringLarge Hadron ColliderATLAS detector010308 nuclear & particles physicsSettore FIS/01 - Fisica SperimentaleHigh Energy Physics::PhenomenologyFísicaSupersymmetryATLASgluinosHADRON-HADRON COLLISIONSExperimental High Energy PhysicsComputingMethodologies_DOCUMENTANDTEXTPROCESSINGsquarksHigh Energy Physics::ExperimentSupersymmetryLHCEvent (particle physics)LeptonModel
researchProduct

Burnout Syndrome in municipal health managers

2016

Resumo Introdução Os gestores municipais da saúde devem responder às demandas de suas equipes e dos pacientes do Sistema Único de Saúde, enfrentando cotidianamente situações potencialmente estressoras. A sobrecarga no trabalho pode levar à exaustão física e mental, com esgotamento dos recursos emocionais, e desencadear a Síndrome de Burnout (SB), cujas consequências podem atingir o serviço gerenciado, uma vez que, ao desempenhar essa atividade laboral, tomam-se decisões determinantes nas ações em saúde que afetam muitas pessoas. Este estudo verificou a presença da SB nos gestores municipais de saúde do Estado de São Paulo. Métodos Estudo do tipo transversal no qual foram coletados dados soc…

Burnout syndromegestor de saúdeAffect (psychology)burnout professional03 medical and health sciencesHealth services0302 clinical medicineNursingMedicinehealth manager030212 general & internal medicineSocioeconomic statussaúde do trabalhadorService (business)030505 public healthDescriptive statisticsbusiness.industryWork overloadUnified Health SystemGeneral MedicineSindrome deoccupational healthSistema Único de SaúdePublic aspects of medicineRA1-12700305 other medical sciencebusinessesgotamento profissionalSocial psychologyCadernos de Saúde Coletiva
researchProduct

APPROCCIO FARMACOLOGICO NEL PAZIENTE CON MALATTIA NON SUSCETTIBILE DI TERAPE LOCO-REGIONALI AD INTENTO CURATIVO.

2006

CARCINOMA PROSTATICO AVANZATO ORMONOTERAPIA ANALOGHI LHRH ANTIANDROGENI TERAPIA IMMEDIATA O RITARDATA TERAPIA INTERMITTENTESettore MED/24 - Urologia
researchProduct

Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and I…

1998

Regulation of gene expression of three putative long-chain fatty acid transport proteins, fatty acid translocase (FAT), mitochondrial aspartate aminotransferase (mAspAT), and fatty acid transport protein (FATP), by drugs that activate peroxisome proliferator-activated receptor (PPAR) alpha and gamma were studied using normal and obese mice and rat hepatoma cells. FAT mRNA was induced in liver and intestine of normal mice and in hepatoma cells to various extents only by PPARalpha-activating drugs. FATP mRNA was similarly induced in liver, but to a lesser extent in intestine. The induction time course in the liver was slower for FAT and FATP mRNA than that of an mRNA encoding a peroxisomal en…

CD36 AntigensMalemedicine.medical_specialtyAdipatesOrganic Anion TransportersReceptors Cytoplasmic and NuclearPeroxisome proliferator-activated receptorWhite adipose tissueBiologyMicrobodiesBiochemistryMiceLiver Neoplasms ExperimentalDiethylhexyl PhthalateInternal medicineBrown adipose tissueTumor Cells CulturedmedicineAnimalsClofibrateRNA MessengerMolecular BiologyDNA Primerschemistry.chemical_classificationMembrane GlycoproteinsBase SequenceFatty Acid Transport ProteinsFatty acidTroglitazoneCell BiologyPeroxisomeRatsPyrimidinesEndocrinologymedicine.anatomical_structureAdipose TissueGene Expression RegulationLiverchemistryPeroxisome proliferator-activated receptor alphaTranscription Factorsmedicine.drugJournal of Biological Chemistry
researchProduct

Alignment of the ATLAS Inner Detector and Single Top Studies

2016

Alineamiento del detector interno de ATLAS y estudios del single top Esta tesis esta compuesta por dos partes bien diferenciadas. La primera trata de los estudios de alineamiento del detector interno del experimento ATLAS en el CERN. La segunda se centra en los estudios sobre el quark top cuando es producido como partícula aislada. ATLAS es uno de los grandes experimentos del LHC (Gran colisionador de hadrones) situado en el CERN. ATLAS es un detector de propósito general. Se diseñó para aprovechar la alta energía disponible en el LHC y observar fenómenos de física a muy altas energías. ATLAS está formado por varios sub-sistemas, como el detector interno de trazas, los calorímetros electrom…

CERNLHCDetectors and Experimental TechniquesATLASSingle TopParticle Physics - ExperimentAlignment
researchProduct

Study of heavy meson production in p-Pb collisions at $\sqrt{S}$=5.02 TeV in the general-mass variable-flavour-number scheme

2017

Nuclear physics / B 925, 415 - 430 (2017). doi:10.1016/j.nuclphysb.2017.10.016

CMSnucleusFOS: Physical sciencesinitial-state interaction530High Energy Physics - PhenomenologyHigh Energy Physics - Phenomenology (hep-ph)CERN LHC CollALICEproduction [bottom]heavy [meson]ddc:530High Energy Physics::Experimentcross section [p p]Nuclear Experimentnumerical calculationscharmproduction [meson]1 [higher-order]
researchProduct